AG00H9R2

10212-25-6 | (-)-Cyclocytidine hydrochloride

AG00H9R2

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	10212-25-6
Catalog Number	AG00H9R2(AGN-PC-00IQQB)
Chemical Name	(-)-Cyclocytidine hydrochloride
EC Number	233-515-6
IUPAC Name	(2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol;hydrochloride
InChI	InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1
InChI Key	KZOWNALBTMILAP-JBMRGDGGSA-N
MDL Number	MFCD00012636
Molecular Formula	C9H12ClN3O4
Molecular Weight	261.6623
SMILES	O[C@@H]1[C@@H](CO)O[C@]2([H])[C@@]1([H])OC3=NC(C=CN32)=N.Cl
UNII	3T6920M469
Synonyms	Ancitabine, Anhydro-Ara-C, Cyclo C, Cyclo-C, CycloC, Cyclocytidine, NSC 145,668, NSC 145668, NSC-145,668, NSC-145668, NSC145,668, NSC145668, U 33,624A, U 33624A, U-33,624A, U-33624A, U33,624A, U33624A, Cyclocytidine hydrochloride, 10212-25-6, Cyclocytidine, 2,2'-O-Cyclocytidine hydrochloride, OCTD hydrochloride, ANCITABINE HYDROCHLORIDE, Ancitabin hydrochlorid, Cyclo-cmp hydrochloride, Cyclocytidine HCl, (-)-Cyclocytidine hydrochloride, ancitabine HCl, 2,2'-Cyclocytidine hydrochloride, 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride, Ancitabine (hydrochloride), 2,2'-Anhydrocytarabine hydrochloride, 2,2'-Anhydroaracytidine hydrochloride, 2,2'-Anhydroarabinosylcytosine hydrochloride, UNII-3T6920M469, EINECS 233-515-6, 2,2'-Cyclocytidine, monohydrochloride, NSC 145668, NSC-145668, O-2,2'-Cyclocytidine monohydrochloride, C9H11N3O4.HCl, Ancitabine hydrochloride [JAN], CHEBI:74843, 2,2'-Anhydrocytidine hydrochloride, MFCD00012636, 2,2'-Anhydro-1beta-D-arabinofuranosylcytosine hydrochloride, 1beta-D-Arabinofuranosylcytosine, 2,2'-anhydro-, hydrochloride, Cyclo-C, 1-beta-D-Arabinofuranosylcytosine, 2,2'-anhydro-, hydrochloride, Cytosine, 1-beta-D-arabinofuranosyl-2,2'-anhydro-, hydrochloride, Cytosine, 1beta-D-arabinofuranosyl-2,2'-anhydro-, hydrochloride, 3T6920M469, Ancitabine hydrochloride (JAN), MLS001173324, Ancitabin HCl, 6H-Furo(2',3':4,5)oxazolo(3,2-a)-pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, stereoisomer, Ancitabin hydrochloride, SMR000538927, cyclocytidine-hcl, AK163009, AC1Q3EVK, AC1L18CC, SCHEMBL98180, 2,2'-Anhydro-(1-beta-D-arabinofuranosyl)cytosine hydrochloride, MLS000766878, MLS001032024, MLS006011603, NSC 145668 HCl, CHEMBL1255937, KZOWNALBTMILAP-JBMRGDGGSA-N, HY-N0093, 2,2'-cyclocytidine monohydrochloride, s1973, 2, 2'-Anhydro-cytidine hydrochloride, AKOS015896930, AC-8697, AN-7748, CS-5313, MCULE-1704179569, AS-12870, BC215746, LS-70869, SC-09085, AB0012527, AX8006959, FT-0083570, ST24046379, O2,2 inverted exclamation marka-Cyclocytidine, C13112, D01651, 698C143, J-700010, Ancitabine hydrochloride (Cyclocytidine hydrochloride), 2,2'-anhydro-(1-beta-D-arabinofuranosylcytosine) hydrochloride, 2,2'-anhydro-1-(beta-D-arabinofuranosyl)cytosine hydrochloride, Cyclocytidine hydrochlorine; 2,2''-O-Cyclocytidine hydrochloride, 2,2 inverted exclamation marka-Anhydro-(1-|A-D-arabinofuranosyl)cytosine hydrochloride, 2,2 inverted exclamation marka-Anhydro-1-|A-D-arabinofuranosylcytosine hydrochloride, (2r,3r,3as,6e,9ar)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6h-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride(1:1), (2R,3R,3aS,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride, (2R,3R,3aS,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride, (2R,3R,3aS,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydrofuro[1,2]oxazolo[3,4-a]pyrimidin-3-ol, (2R,3R,3aS,9aR)-2-(hydroxymethyl)-6-imino-3,3a,6,9a-tetrahydro-2H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ol hydrochloride, (2R,3S,9aR)-2-(hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydrofuro[1,2][1,3]oxazolo[3,4-a]pyrimidin-3-olhydrochloride, 6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, (2R-(2alpha,3beta,3abeta,9abeta))-, 6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, (2R-(2alpha,3beta,3abeta,9abeta))- (9CI), hydrochloride, ANCITABINE, C9H11N3O4.ClH, C9-H11-N3-O4.Cl-H, CID25050, Cyclocytidine hydrochloride, 98% 1g, Cyclocytidine hydrochloride, 98% - 1G 1g, TL8000113, 31698-14-3, 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, [2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.)]-, 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride, stereoisomer,

Complexity	394
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	4
Defined Bond Stereocenter Count	0
Exact Mass	261.052g/mol
Formal Charge	0
Heavy Atom Count	17
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	261.662g/mol
Monoisotopic Mass	261.052g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	98.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number